ICCM Icecure Medical Ltd

  1. Stocks
  2. Healthcare
  3. NASDAQ: ICCM

Price (delayed)

$5.08

Market cap

$412.39M

P/E Ratio

N/A

Dividend/share

$0.07

EPS

-$0.24

Enterprise value

$404.42M

Sign up for free to view scoring metrics ?
Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 11

IceCure Medical Ltd, a medical device company, engages in the research, development, and commercialization of medical devices for cryoablation (freezing) of tumors in the human body. It offers ProSense system, ...

Highlights
The company's debt has shrunk by 63% YoY and by 36% QoQ
The EPS has increased by 14% year-on-year
Icecure Medical's equity has increased by 42% YoY but it has decreased by 6% QoQ
Icecure Medical's quick ratio has increased by 38% YoY but it has decreased by 8% from the previous quarter
Icecure Medical's gross margin has decreased by 15% YoY
The net income has declined by 4.6% since the previous quarter and by 2.9% year-on-year
Sector: Healthcare
Industry: Medical Devices
Website: https://www.icecure-medical.com
Peers: ABT MDT ISRG SYK

Key stats

What are the main financial stats of ICCM

ICCM stock price

How has the Icecure Medical stock price performed over time
Intraday
3,248.71%
1 week
2,127.09%
1 month
1,629.66%
1 year
393.2%
YTD
732.65%
QTD
1,587.71%

Financial performance

How have Icecure Medical's revenue and profit performed over time
Revenue
$3.57M
Gross profit
$1.3M
Operating income
-$15.68M
Net income
-$15.74M
Gross margin
36.5%
Net margin
-441.6%
Icecure Medical's gross margin has decreased by 15% YoY
ICCM's revenue is up by 9% YoY and by 6% QoQ
ICCM's operating margin is up by 8% year-on-year
ICCM's gross profit is down by 7% year-on-year but it is up by 6% since the previous quarter

Price vs fundamentals

How does ICCM's price correlate with its fundamentals

Growth

What is Icecure Medical's growth rate over time

Valuation

What is Icecure Medical stock price valuation
P/E
N/A
P/B
43.73
P/S
104.84
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
113.44
The EPS has increased by 14% year-on-year
The stock's price to book (P/B) is 85% less than its last 4 quarters average of 8.5 and 78% less than its 5-year quarterly average of 5.9
Icecure Medical's equity has increased by 42% YoY but it has decreased by 6% QoQ
The price to sales (P/S) is 83% lower than the 5-year quarterly average of 18.8 and 79% lower than the last 4 quarters average of 15.2
ICCM's revenue is up by 9% YoY and by 6% QoQ

Efficiency

How efficient is Icecure Medical business performance
The ROIC has soared by 59% YoY but it has contracted by 2.5% from the previous quarter
ICCM's ROE is down by 16% YoY but it is up by 4.2% QoQ
The return on sales has increased by 8% year-on-year
ICCM's return on assets is down by 6% year-on-year

Dividends

What is ICCM's dividend history
DPS
$0.07
Dividend yield
1.46%
Payout ratio
N/A
Recent dividends

Special dividends are included in TTM DPS and yield

Financial health

How did Icecure Medical financials performed over time
Icecure Medical's total assets is 177% higher than its total liabilities
Icecure Medical's quick ratio has increased by 38% YoY but it has decreased by 8% from the previous quarter
The current ratio has grown by 33% YoY but it has contracted by 3.4% from the previous quarter
The company's debt is 98% lower than its equity
Icecure Medical's debt to equity has shrunk by 67% YoY
The company's debt has shrunk by 63% YoY and by 36% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.